Health care

The league’s success in Florida shows how the spread of COVID-19 can be controlled by tracking data from digital health devices.

Companies must focus on the social factors that can influence employee performance.

The former director of the CDC and current head of Resolve to Save Lives explains why economic recovery will only arrive when the coronavirus is under control.

Automatic contact tracing in the workplace can help protect employees from COVID-19 while preserving personal privacy.

In their comprehensive new book, Deaths of Despair and the Future of Capitalism, economists Anne Case and Angus Deaton explain why mortality rates in the U.S. are rising.

As officials promote virtual doctor’s visits to curb the spread of coronavirus, this efficient form of care may lower costs.

In the face of a global crisis, well-prepared businesses can help protect their workers and their bottom lines.

What it means for healthcare companies to serve patients effectively is changing. Here’s how understanding and transforming your culture can help you get there.

Why companies need to tread carefully in this unregulated space.

How Beth Mooney, CEO of KeyCorp and chair of the Cleveland Clinic, earns trust in banking and healthcare.

In Priced Out, economist Uwe Reinhardt asks the most taboo question in American healthcare for the last time.

Economists often warn that an abundance of elders will be problematic for the economy. But new research shows that such a demographic shift could be a good thing.

Health sensors that are built into people’s daily lives (and attire) could help researchers address many types of life-threatening crises.

Robert Wachter, M.D., author of The Digital Doctor, is increasingly optimistic that technology can improve healthcare. Better strategic management of people, systems, and data is making a difference.

Companies are embracing stakeholder value to produce results.

Professors Vijay Govindarajan and Ravi Ramamurti offer U.S. healthcare providers a prescription for reverse innovation from India.

How deals are shaping the $450 billion industry that manages prescriptions in the United States.

To compete amid myriad disruptions, insurers in all sectors must wed strategy to structural changes.